Viridian Therapeutics, Inc.\DE (VRDN) Operating income 2016–2025
Viridian Therapeutics, Inc.\DE (VRDN) annual operating income history from SEC filings — each fiscal year as reported.
-$363.4MFY2025 · since FY2016: -$17.0M → -$363.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$363.4M | -21.5% |
| FY2024 | -$299.0M | -17.5% |
| FY2023 | -$254.4M | -89.5% |
| FY2022 | -$134.3M | -68.5% |
| FY2021 | -$79.7M | +27.8% |
| FY2020 | -$110.4M | -162.9% |
| FY2019 | -$42.0M | -26.9% |
| FY2018 | -$33.1M | -24.7% |
| FY2017 | -$26.5M | -56.2% |
| FY2016 | -$17.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice